179 related articles for article (PubMed ID: 20385182)
1. Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
Noh SM; Park MO; Shim G; Han SE; Lee HY; Huh JH; Kim MS; Choi JJ; Kim K; Kwon IC; Kim JS; Baek KH; Oh YK
J Control Release; 2010 Jul; 145(2):159-64. PubMed ID: 20385182
[TBL] [Abstract][Full Text] [Related]
2. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
[TBL] [Abstract][Full Text] [Related]
4. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
5. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
6. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
8. Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes.
Oishi M; Nagasaki Y; Nishiyama N; Itaka K; Takagi M; Shimamoto A; Furuichi Y; Kataoka K
ChemMedChem; 2007 Sep; 2(9):1290-7. PubMed ID: 17546711
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure.
Tamura A; Oishi M; Nagasaki Y
Biomacromolecules; 2009 Jul; 10(7):1818-27. PubMed ID: 19505137
[TBL] [Abstract][Full Text] [Related]
10. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer.
Wang Y; Liu P; Du J; Sun Y; Li F; Duan Y
J Biomater Sci Polym Ed; 2013; 24(10):1219-32. PubMed ID: 23713424
[TBL] [Abstract][Full Text] [Related]
11. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA.
Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A
J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270
[TBL] [Abstract][Full Text] [Related]
12. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation.
Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW
J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of a novel arginine-grafted dendritic block copolymer for gene delivery and study of its cellular uptake pathway leading to transfection.
Kim TI; Baek JU; Yoon JK; Choi JS; Kim K; Park JS
Bioconjug Chem; 2007; 18(2):309-17. PubMed ID: 17315976
[TBL] [Abstract][Full Text] [Related]
14. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells.
Jere D; Jiang HL; Kim YK; Arote R; Choi YJ; Yun CH; Cho MH; Cho CS
Int J Pharm; 2009 Aug; 378(1-2):194-200. PubMed ID: 19501140
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
[TBL] [Abstract][Full Text] [Related]
16. Anionic amino acid-derived cationic lipid for siRNA delivery.
Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK
J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256
[TBL] [Abstract][Full Text] [Related]
17. Development and characterisation of chitosan nanoparticles for siRNA delivery.
Katas H; Alpar HO
J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
[TBL] [Abstract][Full Text] [Related]
18. Chitosan as a carrier for targeted delivery of small interfering RNA.
Rudzinski WE; Aminabhavi TM
Int J Pharm; 2010 Oct; 399(1-2):1-11. PubMed ID: 20732398
[TBL] [Abstract][Full Text] [Related]
19. Folate mediated in vitro targeting of depolymerised trimethylated chitosan having arginine functionality.
Morris VB; Sharma CP
J Colloid Interface Sci; 2010 Aug; 348(2):360-8. PubMed ID: 20580766
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
